FDA.reportPublic FDA data

insulin icodec-abae 1050 UNT in 1.5 ML Pen Injector

RxCUI
2740410
RxNorm name
insulin icodec-abae 1050 UNT in 1.5 ML Pen Injector
Display name
insulin icodec-abae 1050 UNT in 1.5 ML Pen Injector
Full name
insulin icodec-abae 1050 UNT in 1.5 ML Pen Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761326Awiqliinsulin icodec-abae351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5162b93e-5775-4581-a5e9-e8783ae0acd7insulin icodec-abae 1050 UNT in 1.5 ML Pen Injector [PSN] · 1.5 ML insulin icodec-abae 700 UNT/ML Pen Injector [SCD] · insulin icodec-abae 1050 UNT per 1.5 ML Pen Injector [SY]31These highlights do not include all the information needed to use Awiqli ® safely and effectively. See full prescribing information for Awiqli. Awiqli (insulin icodec-abae) injection, for subcutaneous use Initial U.S. Approval: 202620260326